Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: Results from the prospective, longitudinal, observational CoMMpass study Meeting Abstract


Authors: Landgren, O.; Siegel, D. S.; Auclair, D.; Chari, A.; Boedigheimer, M.; Welliver, T.; Mezzi, K.; Iskander, K.; Jakubowiak, A.
Abstract Title: Carfilzomib-lenalidomide-dexamethasone versus bortezomib-lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma: Results from the prospective, longitudinal, observational CoMMpass study
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837602177
PROVIDER: wos
Notes: Meeting Abstract: 799 -- Source: Wos